MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.190
-0.005 (-0.42%)
At close: Sep 18, 2026, 4:00 PM EDT
1.189
-0.001 (-0.07%)
After-hours: Sep 18, 2026, 7:30 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $122.82 million as of September 18, 2026. Its market cap has decreased by -23.20% in one year.
Market Cap
122.82M
Enterprise Value
34.38M
1-Year Change
-23.20%
Ranking
Category
Stock Price
$1.19
ChartMarket Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $122.82M, a decrease of -86.31%. That is a compound annual growth rate of -32.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 122.82M | -25.72% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 14.96% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nyxoah | 158.28M |
| Quantum-Si incorporated | 157.60M |
| Lucid Diagnostics | 151.54M |
| Inogen | 138.00M |
| Owlet | 135.59M |
| Quanterix | 128.64M |
| Apyx Medical | 124.69M |
| Microbot Medical | 96.72M |